This talk will provide a basic overview of the biology of canine mast cell tumors in addition to introducing a new, FDA approved, intratumoral drug for the treatment of nonmetastatic MCT in the dog. Numerous case examples will be shared with attendees, with ample time afforded for Q&A at the end of the presentation.
Presented by Pamela Jones DVM, DACVIM (Oncology), DACVR (Radiation Oncology)
Zoom registration required and limited to current PVMA and OVTAA members. Presentation will be recorded and shared with members for those unable to join us live.
1.5 credit of CE available.